osinophils undergo spontaneous apoptosis in the absence of specific cytokines, which is further accelerated by Fas engagement and glucocorticoids. We have previously shown that interleukin (IL)-5 profoundly affects the processing of caspase 3 in eosinophils, a downstream executioner of apoptosis, but the level of inhibition is unclear. 1 We hypothesized that IL-5 would affect the kinetics of receptor-mediated apoptosis vs non-receptormediated apoptosis differently and that this would be reflected by differential activation of elements presumed to be unique to these pathways.
Materials and Methods
Human peripheral blood eosinophils were cultured in media alone (control), IL-5 (1 ng/mL), dexamethasone (Dex; 1 mol/L), or agonist anti-Fas antibody (500 ng/mL). Viability by trypan, and the processing of caspases 8, 9, and the apoptosis regulatory protein Bid by immunoblot assay were determined at 8, 24, and 48 h. Bid also was examined in fixed eosinophils by immunochemistry.
Results
Anti-Fas and Dex accelerated cell death compared to media alone. IL-5 blocked Dex-induced cell death and slowed cell death induced by anti-Fas. Caspase 8, 9, and Bid processing occurred during both anti-Fas and Dex treatment. Bid was processed to a similar extent during both anti-Fas and Dex stimulation. Furthermore, Dex treatment caused an early shift in cellular Bid staining from its baseline diffuse cytoplasmic pattern to an increasingly punctate one.
Conclusion
Caspases 8, 9, and Bid were processed efficiently in the absence of obvious activation of the Fas receptor, suggesting alternative mechanisms for caspase 8 activation. IL-5 had the ability to modulate the caspase activation at several levels. 
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n humans, the accumulation of CD34ϩ/interleukin (IL)-5 receptor-␣ messenger RNAϩ cells, which presumably include eosinophil progenitors, has been described in the allergen-challenged lung. 1 However, direct evidence for the presence of functionally intact hemopoietic progenitors in the lungs has not yet been reported because this involves procedures and assays that are difficult to carry out with human lungs. Here we describe a procedure for the quantitative recovery of fully functional hemopoietic cells, which accumulate in allergenchallenged mice, from murine lungs.
Materials and Methods
Animals and Animal Procedures
BALB/c mice were immunized following either of the following protocols: (1) sensitization by two subcutaneous 0.4-mL injections of 100 g ovalbumin (OVA) mixed with 1.6 mg Al(OH) 3 (alum) in 0.9% NaCl (saline solution), at 7-day intervals, followed by intranasal challenge with 10 g OVA in 50 L saline solution, 1 week after the second injection 2 ; and (2) sensitization at day 0 by one intraperitoneal 0.2-mL injection of 10 g OVA mixed with alum in saline solution, followed by intranasal challenge at 24-h intervals with 20 g OVA in a 50-L saline solution from day 10 to day 13. Controls were either naive or sensitized mice that had been challenged with saline solution. Animals were killed 24 h after the last challenge. Mice that were anesthetized with thiopental were exsanguinated from the abdominal vena cava. The heparinized blood was used for hemopoietic cell purification. After opening the thoracic cage, an incision was made in the right atrium, and the remaining blood was washed out of the lungs by pumping sterile saline solution through the left atrium. The effectiveness of this procedure in clearing the pulmonary microcirculation was confirmed by histologic examination of anti-CD34-stained lung sections (Tissue-Tek; Elkhart, IN). The lungs were excised and minced in Iscove modified Dulbecco medium (IMDM) in a Petri dish. BAL fluid, blood, and/or spleen cells, in addition to lung tissue, were harvested from naive or sensitized mice.
Isolation and Quantification of Hemopoietic Cells
Turk solution was used for nucleated cell counts; trypan blue was used for the assessment of viability and staining for eosinophil peroxidase (EPO) 3 for the identification of mature and immature eosinophils. Minced lungs were incubated for 20 min at 37°C, with a mixture of 95% air/5% CO 2 , in 10 mL IMDM containing 24 mg collagenase and 0.125 mg DNAase I, before the addition of fetal calf serum (FCS; 20% final) to stop digestion. Lung cell suspensions were obtained by passing fragments through a cell strainer (Falcon 2360) [100 m, nylon], washed twice, counted, and separated on discontinuous gradients (Percoll; Amersham Bioscience; Little Chalfont, Buckinghamshire, UK) [75%, 60%, and 40% Percoll in IMDM] for 20 min, at 100g, at 20°C, with 2 ϫ 10 7 cells per gradient. The low-density mononuclear cells at the 40 to 60% Percoll interface (layer 2) were harvested, washed twice in RPMI medium/FCS, counted, and used for EPO staining and hemopoietic assays. Where indicated, they were stained with rat antimouse CD34 antibody and goat anti-rat IgG fluorescein isothiocyanate conjugate, and were analyzed by flow cytometry (FACScalibur; Becton Dickinson Biosciences; Franklin Lakes, NJ) or were further incubated with ␣ fluorescein isothiocyanate (MicroBeads; Miltenyi Biotech GmbH; Cologne, Germany) for 15 min and separated (Midi-MACS column; Miltenyi Biotec). For bone-marrow, BAL fluid, blood, and spleen cells, triplicate 1-mL semi-solid cultures were plated in methylcellulose in 35-mm culture dishes from 2 ϫ 10 5 cells, in IMDM with 20% FCS, granulocyte-macrophage colonystimulating factor (GM-CSF) [2 ng/mL], IL-3 (2 ng/mL), and IL-5 (1 ng/mL). Colonies were scored at days 7 and 10. Scoring after day 7 did not result in better colony detection, but colony morphology was less preserved. For comparison with lungderived colonies (see below), only counts at day 10 are presented. Unlike bone marrow, colony formation by lung mononuclear cells required the presence of methylcellulose and higher cell densities. Cultures were routinely established with 4 ϫ 10 5 cells in a 1-mL volume, in triplicate. Colonies derived from lung cells grew more slowly than those from bone marrow, but their morphology resembled eosinophil colonies derived from bone marrow. 2 As a rule, counting at day 10 yielded higher counts of lung-derived colonies than at day 7, due to improved colony detection with well-preserved colony morphology. Results always refer to counts at day 10. For typing, individual colonies were aspirated with a micropipette under the inverted microscope, were transferred to microscope slides, and were stained (Panoptic stain or EPO). Results are calculated as the mean Ϯ SEM of progenitor numbers per animal, based on the number of colonies formed by a standard inoculum (lung, 4 ϫ 10 5 cells; BAL and spleen, 2 ϫ 10 5 cells) and on the number of mononuclear cells recovered per animal in each cell source. For blood, the results are presented per milliliter of blood. For all sources of hemopoietic cells, liquid cultures (10 6 cells in a 1-mL volume, in a 24-well cluster 2 ) were seeded in RPMI medium/10% FCS, 2 mmol/L L-glutamine, and penicillin-streptomycin at 37°C, in an atmosphere of 5% CO 2 / 95% air, at least in triplicate, in the presence of GM-CSF (2 ng/mL), IL-3 (2 ng/mL), and IL-5 (1 ng/mL). The frequency of EPOϩ cells was determined at day 7. 2 
Results and Discussion
Significantly higher numbers of low-density mononuclear cells were recovered from sensitized/challenged mice than from naive controls, with an approximate 10-fold increase in mice that were challenged repeatedly with OVA. Very few or no colony-forming cells were present among lung mononuclear cells from naive mice. Sensitization by itself did not significantly increase pro- genitor numbers relative to naive controls. Progenitor numbers were significantly increased in mice sensitized following protocol 1 and challenged with OVA, relative to both naive controls (p ϭ 0.003) and sensitized controls (p ϭ 0.047). Repeated challenges of sensitized mice (protocol 2) did not significantly increased progenitor numbers relative to protocol 1. When lung mononuclear cells were separated into CD34ϩ and CD34Ϫ subpopulations, colonies were formed only from CD34ϩ cells. The frequency of colony-forming cells in the low-density mononuclear fraction from sensitized/challenged lung cells was roughly 1 in every 4,000 cells. This represents an approximate 100-fold enrichment over naive cells from BALB/c mouse lung. For comparison, myeloid progenitors responsive to GM-CSF represent about 1 in every 2,000 bone marrow cells for both naive and sensitized BALB/c mice in our routine culture conditions. 4 Hence, hemopoietic progenitors were approximately one half as frequent in allergic lung as in allergic bone marrow. Eighty-four percent of all lung-derived colonies were EPOϩ, indicating a strong bias toward eosinopoiesis. No significant response to IL-5 was observed in liquid cultures from naive or from sensitized BALB/c mice in the absence of OVA challenge. In contrast, a vigorous response was seen in cultures from challenged, sensitized mice that was comparable in magnitude to that elicited in challenged, sensitized bone marrow. 2, 4 These findings, taken together, indicate that hemopoietic progenitors and precursors selectively accumulate in the murine lung after allergen sensitization and challenge. BAL fluid from sensitized/challenged mice contained very small numbers of colony-forming cells, while large numbers of progenitors could be recovered from digested lung fragments of the same animals. All colonies from BAL were EPOϪ. This shows that progenitor accumulation in the lung cannot be estimated from the numbers of progenitors in BAL fluid. On the other hand, blood and spleen did contain colony-forming cells. The total number of colony-forming cells in the circulation (assuming a total blood volume of 2 mL for the mouse) amounted to two thirds of the total number of progenitors isolated from lung.
Hemopoietic cells isolated from allergic BALB/c mice lungs differed from those in the bone marrow of the same animals in terms of their sensitivity to pharmacologic modulators. As shown in Figure 1 , dexamethasone enhanced the responses of eosinophil precursors from bone marrow to IL-5 but inhibited the responses of eosinophil precursors from the lung under the same conditions. Because, in current models, the suppression of tissue eosinophilia is thought to underlie the therapeutic effects of steroids, 4 hemopoietic cells accumulating in the lungs, unlike those in bone marrow, respond to dexamethasone as predicted from these models. This highlights potentially important differences between these hemopoietic populations.
